Clinical Trial Update: Sodium Chloride and Protein-Bound Toxin Removal in Hemodiafiltration [NA]

View source ↗

Summary

The trial NCT01923961 evaluating sodium chloride and protein-bound toxin removal in hemodiafiltration for end-stage renal disease has completed and results were…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Snippet

Sponsor: EXcorLab GmbH | Conditions: End-stage Renal Disease | NA | Status: COMPLETED | Results posted: 2019-01-16